Co-enzyme Q10 (CoQun®) eye drops are indicated as a complementary add-on treatment to antihypertensive glaucoma therapy.
|NCPE Assessment Process||Complete|
|Rapid review commissioned||16th October 2019|
|Rapid review completed||13th January 2020|
|Rapid Review outcome||A full HTA is not recommended. The NCPE recommends that CoQ10 eye drops not be considered for reimbursement*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.